BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8782236)

  • 1. Evaluation of 1-azabicyclo[2.2.2]oct-3-yl alpha-fluoroalkyl-alpha-hydroxy-alpha-phenylacetates as potential ligands for the study of muscarinic receptor density by positron emission tomography.
    Luo H; Hasan A; Sood V; McRee RC; Zeeberg B; Reba RC; McPherson DW; Knapp FF
    Nucl Med Biol; 1996 Apr; 23(3):267-76. PubMed ID: 8782236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution and in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate: a high-affinity ligand for the muscarinic receptor.
    McPherson DW; Lambert CR; Jahn K; Sood V; McRee RC; Zeeberg B; Reba RC; Knapp FF
    J Med Chem; 1995 Sep; 38(20):3908-17. PubMed ID: 7562924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
    McPherson DW; DeHaven-Hudkins DL; Callahan AP; Knapp FF
    J Med Chem; 1993 Apr; 36(7):848-54. PubMed ID: 8464039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Z-(R,R)-IQNP for the potential imaging of m2 mAChR rich regions of the brain and heart.
    McPherson DW; Greenbaum M; Luo H; Beets AL; Knapp FF
    Life Sci; 2000; 66(10):885-96. PubMed ID: 10714889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease.
    Bergström KA; Halldin C; Savonen A; Okubo Y; Hiltunen J; Nobuhara K; Swahn CG; Karlsson P; McPherson D; Knapp FF; Larsson S; Schnell PO; Farde L
    Eur J Nucl Med; 1999 Nov; 26(11):1482-5. PubMed ID: 10552091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo autoradiographic and dissection evaluation of isomers of 125I-labeled 1-azabicyclo[2.2.2] oct-3-yl-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IQNP).
    Rayeq MR; Boulay SF; Sood VK; McPherson DW; Knapp FF; Zeeberg BR
    Recept Signal Transduct; 1996; 6(1):13-34. PubMed ID: 8933619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP.
    Nobuhara K; Farde L; Halldin C; Karlsson P; Swahn CG; Olsson H; Bergström KA; Larsson SA; Schnell PO; McPherson DW; Savonen A; Hiltunen J; Sedvall G
    Eur J Nucl Med; 2001 Jan; 28(1):13-24. PubMed ID: 11202446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease.
    Nobuhara K; Halldin C; Hall H; Karlsson P; Farde L; Hiltunen J; McPherson DW; Savonen A; Bergström KA; Pauli S; Swahn CG; Larsson SA; Schnell PO; Sedvall G
    Psychopharmacology (Berl); 2000 Mar; 149(1):45-55. PubMed ID: 10789882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and simple Sep Pak method for purification of radioiodinated IQNP, a high affinity ligand for the muscarinic receptor.
    McPherson DW; Knapp FF
    Nucl Med Biol; 1999 Oct; 26(7):859-63. PubMed ID: 10628569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB.
    Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Knapp FF
    Recept Signal Transduct; 1997; 7(1):45-54. PubMed ID: 9285530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and metabolite studies of 125I- and 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain.
    Bergström KA; Halldin C; Hiltunen J; Swahn CG; Ito H; Ginovart N; Hall H; McPherson DW; Knapp FF; Larsson S; Schnell PO; Farde L
    Nucl Med Biol; 1998 Apr; 25(3):209-14. PubMed ID: 9620625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.
    Cohen VI; Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Reba RC
    J Mol Neurosci; 1998 Aug; 11(1):1-9. PubMed ID: 9826782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled ligands for imaging the muscarinic-cholinergic receptors of the heart and brain.
    Knapp FF; McPherson DW; Luo H; Zeeburg B
    Anticancer Res; 1997; 17(3B):1559-72. PubMed ID: 9179195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNB.
    Gitler MS; Boulay SF; Sood VK; McPherson DW; Knap FF; Zeeberg BR; Reba RC
    Brain Res; 1995 Jul; 687(1-2):71-8. PubMed ID: 7583315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective synthesis and biodistribution of potent [11C]-labeled antagonists for positron emission tomography imaging of muscarinic receptors in the airways.
    Visser TJ; van Waarde A; Jansen TJ; Visser GM; van der Mark TW; Kraan J; Ensing K; Vaalburg W
    J Med Chem; 1997 Jan; 40(1):117-24. PubMed ID: 9016336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands.
    Kiesewetter DO; Carson RE; Jagoda EM; Herscovitch P; Eckelman WC
    Life Sci; 1999; 64(6-7):511-8. PubMed ID: 10069517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis, in vitro, and initial in vivo evaluation of 1-methylpiperidin-4-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IPIP): a novel radioiodinated molecular probe with high affinity for the muscarinic receptor.
    McPherson DW; Breeden WK; Beets AL; Luo H; Sood V; Knapp FF
    Nucl Med Biol; 2001 Nov; 28(8):959-73. PubMed ID: 11711316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands.
    Hewlett WA; Schmidt DE; Mason NS; Trivedi BL; Ebert MH; de Paulis T
    Nucl Med Biol; 1998 Feb; 25(2):141-53. PubMed ID: 9468029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo metabolic studies of the trans-(R,R) isomer of radioiodinated IQNP: a new ligand with high affinity for the M1 muscarinic-cholinergic receptor.
    McPherson DW; Lambert CR; Knapp FF
    Eur J Nucl Med; 1994 Dec; 21(12):1293-7. PubMed ID: 7875166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain.
    Lee J; Paik CH; Kiesewetter DO; Park SG; Eckelman WC
    Nucl Med Biol; 1995 Aug; 22(6):773-81. PubMed ID: 8535338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.